OncoCyte Senior Management Rings NYSE Opening Bell

Investor Relations

OncoCyte is focused on the discovery, development and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer.




Corporate Profile


OncoCyte Chairman and CEO at Bell ringing ceremony

Stock Information
Events & Presentation

No upcoming events scheduled at this time.

Latest News
OncoCyte and The Wistar Institute Present Lung Cancer Diagnostic Data at the CHEST 2016 Annual Meeting
OncoCyte Corporation to Present at the BIO Investor Forum